Gentherm Incorporated (THRM)

Lumos Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	128.3	134.13	149.67	153.89	190.61	268.35
Trading Asset Securities	-	0.72	2.06	2.77	-	-
Cash & Short-Term Investments	128.3	134.85	151.74	156.66	190.61	268.35
Cash Growth	2.21%	-11.13%	-3.15%	-17.81%	-28.97%	431.98%
Accounts Receivable	318.8	278.96	274.88	267.89	186.77	216.5
Other Receivables	23.32	20.61	16.02	15.04	10.68	10.51
Receivables	354.54	310.76	309.12	295.06	210.48	246.22
Inventory	248.38	227.36	205.89	218.25	159.48	122.4
Prepaid Expenses	12.71	6.31	7.89	6.24	3.41	3.93
Other Current Assets	14.89	4.74	12.93	7.66	1.88	2.71
Total Current Assets	758.82	684.02	687.56	683.87	565.85	643.61
Property, Plant & Equipment	321.93	296.92	272.59	274.43	179.66	183.22
Long-Term Investments	-	3.9	-	-	5.2	-
Goodwill	108.89	99.6	104.07	119.77	66.03	68.02
Other Intangible Assets	55.91	57.25	66.48	73.93	37.55	46.42
Long-Term Deferred Tax Assets	78.34	75.04	81.93	69.84	69.63	73.91
Long-Term Deferred Charges	0.17	14.28	7.31	2.24	1.95	-
Other Long-Term Assets	37.35	16.55	14.43	15.22	9.48	7.65
Total Assets	1,361	1,248	1,234	1,239	935.34	1,023
Accounts Payable	254.13	226.82	215.83	182.23	122.73	116.04
Accrued Expenses	62.62	62.78	66.09	58.67	56.16	49.52
Current Portion of Long-Term Debt	-	-	0.62	2.44	2.5	2.5
Current Portion of Leases	10.06	7.65	7.7	7.14	5.67	6.03
Current Income Taxes Payable	28.56	26.39	19.33	14.46	17.07	14.71
Other Current Liabilities	21.55	16.66	15.39	20.68	8.96	17.17
Total Current Liabilities	376.93	340.29	324.95	285.63	213.09	205.98
Long-Term Debt	209	220	221.61	231.57	36.25	189.93
Long-Term Leases	51.14	37.12	16.78	21.62	19.79	24.23
Other Long-Term Liabilities	20.69	29.18	23.1	24.57	5.58	8.19
Total Liabilities	661.66	630.61	589.65	567.03	281.54	436.51
Common Stock	-	2.05	50.5	122.66	118.65	121.07
Additional Paid-In Capital	1.59	4.29	-	5.45	5.87	7.46
Retained Earnings	696.15	695.8	624.38	590.66	566.22	472.78
Comprehensive Income & Other	2.01	-85.19	-30.16	-46.49	-36.92	-14.98
Shareholders' Equity	699.75	616.95	644.72	672.27	653.81	586.33
Total Liabilities & Equity	1,361	1,248	1,234	1,239	935.34	1,023
Total Debt	270.19	264.77	246.71	262.78	64.21	222.7
Net Cash (Debt)	-141.9	-129.92	-94.98	-106.11	126.4	45.65
Net Cash Growth	-	-	-	-	176.91%	-
Net Cash Per Share	-4.58	-4.13	-2.87	-3.17	3.77	1.38
Filing Date Shares Outstanding	30.52	30.79	31.54	33.21	33.02	32.94
Total Common Shares Outstanding	30.52	30.79	31.54	33.2	33.01	32.92
Working Capital	381.89	343.72	362.61	398.24	352.76	437.62
Book Value Per Share	22.93	20.04	20.44	20.25	19.81	17.81
Tangible Book Value	534.95	460.09	474.17	478.57	550.22	471.89
Tangible Book Value Per Share	17.53	14.94	15.03	14.41	16.67	14.33
Buildings	-	117.95	130.37	123.71	100.79	99.01
Machinery	-	298.34	264.31	239.18	180.64	165.62
Construction In Progress	-	36.85	27.46	29.02	14.51	8.97
Leasehold Improvements	-	23.26	12.27	12.27	11.45	11.76

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q